Trial Profile
Arnuity Ellipta Drug Use Investigation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Asthma
- Focus Adverse reactions; Therapeutic Use
- Sponsors GlaxoSmithKline
- 22 Apr 2021 Status changed from recruiting to completed.
- 26 Oct 2017 Status changed from not yet recruiting to recruiting.
- 06 Jul 2017 Planned initiation date changed from 1 Jul 2017 to 31 Aug 2017.